ORCHID PHARMA
Back to Balance Sheet
|
ORCHID PHARMA Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Deferred Tax Assets / Liabilities | - | ₹3.23 Cr | ₹3.23 Cr | ₹3.23 Cr | ₹3.23 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of ORCHID PHARMA ?
Year | Deferred Tax Assets / Liabilities |
---|---|
Mar2024 | - |
Mar2023 | ₹3.23 Cr |
Mar2022 | ₹3.23 Cr |
Mar2021 | ₹3.23 Cr |
Mar2020 | ₹3.23 Cr |
How is Deferred Tax Assets / Liabilities of ORCHID PHARMA Trending?
Years | Deferred Tax Assets / Liabilities | % Change | |
---|---|---|---|
Mar2024 | - | -100.00 | |
Mar2023 | ₹3.23 Cr | 0.00 | |
Mar2022 | ₹3.23 Cr | 0.00 | |
Mar2021 | ₹3.23 Cr | 0.00 | |
Mar2020 | ₹3.23 Cr | - |
Compare Deferred Tax Assets / Liabilities of peers of ORCHID PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
ORCHID PHARMA | ₹3,752.3 Cr | 4.2% | 2.3% | -48.7% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹409,219.0 Cr | 0.4% | 1.7% | 2% | Stock Analytics | |
DIVIS LABORATORIES | ₹175,227.0 Cr | -0.3% | -3.8% | 35.5% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹126,643.0 Cr | 3.9% | 11.8% | 20% | Stock Analytics | |
CIPLA | ₹125,541.0 Cr | 1.5% | 3.8% | 2% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹106,063.0 Cr | -0.5% | -0.1% | -5.1% | Stock Analytics |
ORCHID PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
ORCHID PHARMA | 4.2% |
2.3% |
-48.7% |
SENSEX | -1.2% |
-3% |
-0.2% |
You may also like the below Video Courses